Eosinophilia is a condition in which eosinophils are produced in high levels. Eosinophils are white blood cells that destroy foreign substances and promote inflammation. Eosinophilia has a number of different causes, including toxins, allergies, parasitic or fungal infections, autoimmune diseases, and several types of cancer. The two major types of Eosinophilia are Tissue Eosinophilia, in which the white blood cells are overexpressed in tissue, and Blood Eosinophilia, in which the blood has high levels of Eosinophils. The disease is often discovered when a doctor orders a blood test for a different set of symptoms. The discovery of Eosinophilia in an individual can help lead to an accurate diagnosis. Because Eosinophilia is the result of a different disease, there is no official treatment other than to treat the initial disease.
Eosinophilia Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Eosinophilia below!
For more information on how to use Laverne, please read the How to Guide.
We have 3722 products for the study of Eosinophilia that can be applied to Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Eosinophilia is also known as eosinophilia, disorder characterized by eosinophilia, eosinophilic leukocytosis, eosinophil count raised.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.